Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja Reuter

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Lancet (London, England)|December 15, 2022
Celebrating choice in the care of people living with drug-resistant tuberculosisAnja Reuter, Jennifer Furin
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 9, 2020
Treating Drug-resistant Tuberculosis Infection: No More ExcusesAnja Reuter, Jennifer Furin
The Lancet. HIV|March 26, 2022
Helping hospitals heal people with HIV and tuberculosisAnja Reuter, Jennifer Furin
Pathogens (Basel, Switzerland)|May 27, 2023
Treatment of Infection as a Core Strategy to Prevent Rifampicin-Resistant/Multidrug-Resistant TuberculosisAnja Reuter, Jennifer Furin
The Lancet. Infectious Diseases|June 21, 2025
Unified global action needed to tackle bedaquiline-resistant tuberculosisAnja Reuter, Jennifer Furin
Lancet (London, England)|September 15, 2018
Reducing harm in the treatment of multidrug-resistant tuberculosisAnja Reuter, Jennifer Furin
The Lancet. Respiratory Medicine|July 14, 2018
Bedaquiline use in South Africa reveals a lifesaving policy in actionAnja Reuter, Jennifer Furin
The Lancet. HIV|July 5, 2020
The problem with vitamin D supplementation for tuberculosisAnja Reuter, Jennifer Furin
Current Opinion in HIV and AIDS|November 9, 2018
Demanding an end to tuberculosis: treatment of tuberculosis infection among persons living with and without HIVJustine Fargher, Anja Reuter, Jennifer Furin
Lancet (London, England)|September 19, 2019
Challenges and controversies in childhood tuberculosisAnja Reuter, Jennifer Hughes, Jennifer Furin
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Lancet (London, England)|December 15, 2022
Celebrating choice in the care of people living with drug-resistant tuberculosisAnja Reuter, Jennifer Furin
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 9, 2020
Treating Drug-resistant Tuberculosis Infection: No More ExcusesAnja Reuter, Jennifer Furin
The Lancet. HIV|March 26, 2022
Helping hospitals heal people with HIV and tuberculosisAnja Reuter, Jennifer Furin
Pathogens (Basel, Switzerland)|May 27, 2023
Treatment of Infection as a Core Strategy to Prevent Rifampicin-Resistant/Multidrug-Resistant TuberculosisAnja Reuter, Jennifer Furin
The Lancet. Infectious Diseases|June 21, 2025
Unified global action needed to tackle bedaquiline-resistant tuberculosisAnja Reuter, Jennifer Furin
Lancet (London, England)|September 15, 2018
Reducing harm in the treatment of multidrug-resistant tuberculosisAnja Reuter, Jennifer Furin
The Lancet. Respiratory Medicine|July 14, 2018
Bedaquiline use in South Africa reveals a lifesaving policy in actionAnja Reuter, Jennifer Furin
The Lancet. HIV|July 5, 2020
The problem with vitamin D supplementation for tuberculosisAnja Reuter, Jennifer Furin
Current Opinion in HIV and AIDS|November 9, 2018
Demanding an end to tuberculosis: treatment of tuberculosis infection among persons living with and without HIVJustine Fargher, Anja Reuter, Jennifer Furin
Lancet (London, England)|September 19, 2019
Challenges and controversies in childhood tuberculosisAnja Reuter, Jennifer Hughes, Jennifer Furin
Pageof 4